tradingkey.logo
tradingkey.logo
Search

Denali Therapeutics Inc

DNLI
Add to Watchlist
24.040USD
+0.470+1.99%
Close 07-27 16:00ETQuotes delayed by 15 min
3.81BMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Baillie Gifford & Co.
7.60%
BlackRock Institutional Trust Company, N.A.
6.56%
T. Rowe Price Investment Management, Inc.
4.57%
Biogen Inc
4.51%
Temasek Holdings Pte. Ltd.
4.42%
Other
72.34%
Shareholders
Shareholders
Proportion
Baillie Gifford & Co.
7.60%
BlackRock Institutional Trust Company, N.A.
6.56%
T. Rowe Price Investment Management, Inc.
4.57%
Biogen Inc
4.51%
Temasek Holdings Pte. Ltd.
4.42%
Other
72.34%
Shareholder Types
Shareholders
Proportion
Investment Advisor
52.46%
Investment Advisor/Hedge Fund
21.59%
Hedge Fund
14.03%
Sovereign Wealth Fund
7.64%
Individual Investor
4.62%
Corporation
4.51%
Research Firm
2.29%
Bank and Trust
1.11%
Private Equity
0.63%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
555
158.73M
100.01%
+922.46K
2025Q4
520
148.33M
104.72%
+27.93K
2025Q3
534
148.30M
106.07%
+2.76M
2025Q2
533
144.90M
104.92%
+4.11M
2025Q1
521
140.91M
100.82%
-5.51M
2024Q4
508
135.26M
104.03%
-2.70M
2024Q3
500
139.34M
103.43%
+2.39M
2024Q2
486
129.82M
93.98%
+2.48M
2024Q1
475
127.09M
84.98%
+6.07M
2023Q4
485
116.85M
84.85%
+2.16M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Baillie Gifford & Co.
12.31M
7.76%
+719.30K
+6.21%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
10.41M
6.56%
+283.36K
+2.80%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
7.25M
4.57%
+1.62M
+28.65%
Dec 31, 2025
Biogen Inc
7.16M
4.51%
-5.60M
-43.89%
Oct 30, 2024
Temasek Holdings Pte. Ltd.
7.01M
4.42%
+1.66M
+30.94%
Dec 31, 2025
State Street Investment Management (US)
6.26M
3.95%
+799.11K
+14.62%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
5.12M
3.23%
+1.17M
+29.70%
Dec 31, 2025
Fidelity Management & Research Company LLC
4.79M
3.02%
-223.13K
-4.45%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Neuroscience and Healthcare ETF
4.13%
Global X Guru Index ETF
1.33%
ALPS Medical Breakthroughs ETF
0.98%
Virtus LifeSci Biotech Clinical Trials ETF
0.74%
State Street SPDR S&P Biotech ETF
0.73%
Direxion Daily S&P Biotech Bull 3X Shares
0.45%
Global X Aging Population ETF
0.38%
ProShares Ultra Nasdaq Biotechnology
0.35%
iShares Health Innovation Active ETF
0.35%
Invesco Nasdaq Biotechnology ETF
0.23%
View more
iShares Neuroscience and Healthcare ETF
Proportion4.13%
Global X Guru Index ETF
Proportion1.33%
ALPS Medical Breakthroughs ETF
Proportion0.98%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.74%
State Street SPDR S&P Biotech ETF
Proportion0.73%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0.45%
Global X Aging Population ETF
Proportion0.38%
ProShares Ultra Nasdaq Biotechnology
Proportion0.35%
iShares Health Innovation Active ETF
Proportion0.35%
Invesco Nasdaq Biotechnology ETF
Proportion0.23%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.